[EN] SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS<br/>[FR] DÉRIVÉS DE 3-AZABICYCLO[3.1.0]HEXANE SUBSTITUÉS UTILES EN TANT QU'ANTAGONISTES DE CCR2
申请人:MERCK SHARP & DOHME
公开号:WO2012125661A1
公开(公告)日:2012-09-20
Disclosed are CCR2 antagonists of Formula (I)or pharmaceutically acceptable thereof, wherein R1, L1 and A are defined herein. Also disclosed are pharmaceutical compositions containing the compounds, methods of treatment using the compounds, and compositions to treat diseases or disorders associated with CCR2 activity.
揭示了公式(I)的CCR2拮抗剂或其药用可接受物,其中R1、L1和A在此处有定义。还披露了含有这些化合物的药物组合物、使用这些化合物的治疗方法,以及用于治疗与CCR2活性相关的疾病或障碍的组合物。